Medplus Health Services Ltd (MEDPLUS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Medplus Health Services Ltd on NSE and BSE, with an AI summary of each filing.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 31 Oct 2026, 3:40 pm
Medplus Health Promoter Pledges Additional Shares for Security Cover Agilemed Investments Private Limited, promoter of Medplus Health Services Limited, pledged an additional 9,75,000 equity shares (0.81% of total share capital) on 23rd Oct'26 in favour of Catalyst Trusteeship Limited to maintain the required Security Cover Ratio for existing unlisted NCDs held by Modulus Alternatives and Neo debenture holders. No fresh borrowings were raised. Following this creation, Agilemed holds 1,44,02,525 shares (11.99% of total share capital) under pledge, taking the total promoter group encumbered holding to 3,85,52,925 shares, or 79.85% of total promoter shareholding.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 31 Oct 2026, 3:39 pm
Medplus Health Promoter Pledges Additional 1.50% Stake to Maintain NCD Security Cover Promoter Lone Furrow Investments created an additional pledge of 18,00,000 equity shares (1.50% of total share capital) of Medplus Health Services on 23rd Oct'26 in favour of Catalyst Trusteeship for Avendus Finance. The encumbrance restores the required security cover ratio of 2.10x for existing NCD facilities worth INR 550 Cr, involving no fresh borrowings. Post-transaction, Lone Furrow holds 88,00,000 pledged shares (7.32% of total capital), raising overall promoter group encumbered shares to 3,85,52,925 shares, representing 79.85% of total promoter holding and 32.07% of the company's equity capital.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 30, 2026 for Agilemed Investments Pvt Ltd
Encumbered Shares - Invocation / Release · 31 Oct 2026, 3:34 pm
Medplus Health Promoter Agilemed Creates Additional Pledge on 9.75 Lakh Shares Agilemed Investments Private Limited, promoter of Medplus Health Services Limited, created additional pledges on 9,75,000 equity shares (0.81% of total share capital) on 23rd Oct'26. The pledge includes 5,00,000 shares for NCDs held by Modulus Alternatives Investment Managers and 4,75,000 shares for NCDs held by Neo debenture holders via Catalyst Trusteeship. The top-up was executed solely to maintain required Security Cover Ratios under existing NCD facilities without any fresh borrowing. Post-transaction, Agilemed holds 1,44,02,525 shares (11.99% of company capital) under encumbrance.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 30, 2026 for Lone Furrow Investments Pvt Ltd
Encumbered Shares - Invocation / Release · 31 Oct 2026, 3:33 pm
Medplus Health Promoter Pledges Additional 1.50% Stake to Maintain Security Cover Lone Furrow Investments Private Limited, a promoter entity of Medplus Health Services Limited, created an additional pledge of 18,00,000 equity shares (1.50% of total share capital) on 23rd Oct'26 in favour of Catalyst Trusteeship Limited for existing NCD facilities with Avendus Finance Private Limited. The pledge was created solely to restore the required 2.10x Security Cover Ratio, involving no fresh borrowing. Consequently, Lone Furrow's total pledged shares increased to 88,00,000 (7.32% of total share capital), bringing overall promoter group encumbrance to 3,85,52,925 shares (79.85% of promoter holding; 32.09% of total capital).
MEDPLUS HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to consider Buyback.
Intimation · 30 Oct 2026, 11:09 pm
Medplus Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation · 30 Oct 2026, 11:08 pm
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Buy-Back of Equity Shares.
Intimation · 30 Oct 2026, 10:59 pm
MedPlus Health Services Board to Consider Share Buyback on 6th Nov'26 MedPlus Health Services Limited has scheduled a Board of Directors meeting on 6th Nov'26 to evaluate and approve a proposal for the buyback of fully paid-up equity shares. In accordance with SEBI insider trading regulations, the trading window for designated persons and their immediate relatives has been closed effective 30th Oct'26 and will reopen 48 hours after the board's decision regarding the buyback proposal is publicly disclosed.
Intimation of Board Meeting to consider buyback for equity shares
Intimation · 30 Oct 2026, 10:59 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Acquisition/ Disposal of Shares · 30 Oct 2026, 10:42 pm
ICICI Prudential Mutual Fund Raises Stake in Medplus Health Services to 9.21% ICICI Prudential Mutual Fund increased its holding in Medplus Health Services Ltd. by 2.03% via open market purchases between 21st Aug'26 and 29th Oct'26. The fund executed a net acquisition of 24,35,693 shares, which included buying 56,210 shares on 29th Oct'26 that triggered the 2% disclosure threshold under SEBI SAST Regulations. Consequently, the fund's total shareholding expanded from 86,23,690 shares (7.18% of voting capital) to 1,10,59,383 shares (9.21% of total voting capital and 9.20% of diluted capital), held purely for investment purposes.
Submission of Audio Recordings of Earnings Call
Audio / Video · 28 Oct 2026, 11:25 pm
MedPlus Releases Q2 FY27 Earnings Call Audio Recording MedPlus Health Services Limited submitted the audio recording of its earnings conference call held on 28th Oct'26 at 16:00 Hrs IST. The call discussed the company's financial results for the quarter and half-year ended 30th Sep'26 with analysts and institutional investors. The recording has been made publicly accessible on the company's website as well as the BSE and NSE platforms pursuant to Regulation 30(6) of SEBI LODR Regulations.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition/ Disposal of Shares · 28 Oct 2026, 4:01 pm
Catalyst Trusteeship Discloses Additional Share Pledge in MedPlus Health Services Catalyst Trusteeship Limited, acting as Debenture Trustee, disclosed the creation of a pledge over 34,00,000 equity shares (2.83% of total voting capital) of MedPlus Health Services Limited on 29th Sep'26 and 23rd Oct'26. Following this encumbrance, Catalyst Trusteeship’s total pledged shareholding in the company increased from 2,07,50,400 shares (17.27% of voting capital; 17.26% diluted) to 2,41,50,400 shares, representing 20.10% of total voting capital (20.09% on a diluted basis). Total equity share capital remains unchanged at 12,01,37,061 shares.
Presentation for Earning calls with Analysts/Institutional Investors on Un-Audited Financial Results for the quarter and half year ended September 30, 2026
Investor Presentation · 28 Oct 2026, 12:16 am
MedPlus Health Services Delivers Strong Q2FY27 Topline Growth and Margin Expansion MedPlus reported Q2FY27 revenue of ₹20,371.1m, up 21.3% YoY and 8.4% QoQ. Gross margin stood at 25.1%, contracting 110 bps YoY but expanding 60 bps QoQ. Operating EBITDA surged 50.7% QoQ to ₹981.1m (4.8% margin), while consolidated EBITDA reached ₹1,906.0m (9.4% margin). PAT grew 69.1% QoQ to ₹560.7m. The company added 166 net stores, expanding its total network to 5,642 stores across 860+ cities as of 30th Sep'26. Mature stores (>12 months) posted 13.2% YoY revenue growth and a 72.0% operating ROCE.
Allotment of equity shares under the MedPlus Employee Stock Option Scheme 2021
Others (Uncategorized) · 28 Oct 2026, 12:09 am
MedPlus Health Approves ESOP Share Allotment MedPlus Health Services approved the allotment of 19,095 equity shares (face value Rs. 2 each) on 27th Oct'26 under its ESOP 2021 scheme at an exercise price of Rs. 232 per share, including a premium of Rs. 230 per share. Following this allotment, the company's paid-up equity share capital increased from Rs. 24,02,74,122 (12,01,37,061 shares) to Rs. 24,03,12,312 (12,01,56,156 shares). The newly issued shares rank pari passu with existing equity shares.
Outcome of Board Meeting under SEBI (Listing Obligation and Disclosure requirements) Regulations 2015 (Listing Regulations)
Financial Result · 28 Oct 2026, 12:00 am
Outcome of Board meeting under SEBI (Listing Obligation and Disclosure requirements) Regulations 2015 (Listing Regulations)
Outcome · 27 Oct 2026, 11:39 pm
MedPlus Health Services Reports Q2 FY27 Consolidated Results with Revenue Growth MedPlus Health Services reported consolidated revenue from operations of ₹20,371.08m for the quarter ended 30th Sep'26, up 21.3% YoY from ₹16,793.29m in Q2 FY26 and up 8.4% QoQ from ₹18,796.00m. Profit before tax reached ₹701.47m versus ₹689.35m in Q2 FY25. Net profit after tax stood at ₹560.69m, compared to ₹555.02m YoY and ₹331.67m QoQ, with basic EPS rising to ₹4.73. Separately, the board approved the allotment of 19,095 equity shares under its ESOP 2021 scheme.
Outcome of Board meeting under SEBI (Listing Obligation and Disclosure requirements)Regulations 2015 (Listing Regulations)
Outcome · 27 Oct 2026, 11:38 pm
Medplus Health Services Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 20,371 (+21.3% YoY | +8.4% QoQ) ■ EBITDA: 1,701 (+14.2% YoY | +27.6% QoQ) ■ EBITDA Margin (%): 8.3 (-52 bps YoY | +126 bps QoQ) ■ PAT: 561 (+1.0% YoY | +69.0% QoQ) ■ EPS (INR): 4.72 (+2.2% YoY | +71.0% QoQ) Medplus Health Services Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Retail ■ Revenue: 19,958 (+21.3% YoY | +8.3% QoQ) ■ EBIT: 558 (-5.8% YoY | +76.6% QoQ) ■ EBIT Margin (%): 2.8 (-80 bps YoY | +108 bps QoQ) Diagnostic services ■ Revenue: 411 (+23.5% YoY | +10.7% QoQ) ■ EBIT: 49.3 (+2281.6% YoY | +112.1% QoQ) ■ EBIT Margin (%): 12.0 (+1139 bps YoY | +574 bps QoQ) Others ■ Revenue: 2.9 (-34.7% YoY | +116.7% QoQ) ■ EBIT: 1.7 (-43.7% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 60.8 (-971 bps YoY | Loss to Profit QoQ)
Intimation of Earnings Calls for the quarter and half-year ended September 30, 2026
Intimation · 28 Oct 2026, 4:00 pm
MedPlus Health Services Schedules Q2 FY27 Earnings Call on 28th Oct'26 MedPlus Health Services Limited has scheduled its earnings call for analysts and institutional investors on Wednesday, 28th Oct'26, at 16:00 IST. The call will discuss the company's un-audited financial results for the quarter and half-year ended 30th Sep'26. Investors can pre-register via Diamond Pass or dial in using universal (+91 22 6280 1267 / +91 22 7115 8223) and international toll-free numbers.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 08 Oct 2026, 1:10 am
Lone Furrow Pledges Additional 1.33% Stake in Medplus Health Services Lone Furrow Investments Private Limited, promoter of Medplus Health Services Limited, created an additional pledge of 16,00,000 equity shares (1.33% of total share capital) on 29th Sep'26 in favour of Catalyst Trusteeship Limited for debenture holder Avendus Finance Private Limited. The pledge maintains the required security cover ratio for existing unlisted NCDs, with no fresh borrowings raised. Post-transaction, Lone Furrow holds 70,00,000 pledged shares (5.83% of total share capital), raising total promoter encumbered shares across PACs to 3,52,27,925 shares (72.96% of promoter holding).
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
Encumbered Shares - Invocation / Release · 08 Oct 2026, 1:09 am
Agilemed Investments Pledges Additional Medplus Health Shares to Maintain Security Cover Agilemed Investments Private Limited, a promoter of Medplus Health Services Limited, created additional pledges on 5,50,000 equity shares (0.46% of total share capital) on 30th Sep'26 in favour of Catalyst Trusteeship Limited to maintain the required Security Cover Ratio for existing unlisted NCDs. The pledge includes 3,00,000 shares for Modulus Alternatives Investment Managers and 2,50,000 shares for Neo debenture holders, with no fresh borrowings involved. Following this creation, Agilemed's encumbered holding increased to 1,34,27,525 shares (11.18% of total share capital). Total promoter encumbrance stands at 74.10%.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 07, 2026 for Lone Furrow Investments Pvt Ltd
Encumbered Shares - Invocation / Release · 08 Oct 2026, 1:07 am
Medplus Health Promoter Pledges Additional 1.33% Stake for Security Cover Medplus Health Services promoter Lone Furrow Investments pledged an additional 16,00,000 equity shares (1.33% of total share capital) on 29th Sep'26 in favour of Catalyst Trusteeship Limited for debenture holder Avendus Finance. The pledge was created solely to maintain the security cover ratio under existing unlisted NCD facilities, with no fresh borrowing involved. Following this transaction, Lone Furrow’s pledged shares increased to 70,00,000 (5.83% of total capital), bringing total promoter encumbered shares to 3,52,27,925, representing 72.96% of total promoter shareholding.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 07, 2026 for Agilemed Investments Pvt Ltd
Encumbered Shares - Invocation / Release · 08 Oct 2026, 1:06 am
Agilemed Investments Pledges Additional 0.46% Stake in Medplus Health Services Promoter Agilemed Investments created an additional pledge of 5,50,000 equity shares (0.46% of total share capital) of Medplus Health Services on 30th Sep'26 in favour of Catalyst Trusteeship to maintain security cover ratios for existing NCDs held by Modulus Alternatives and Neo debenture holders, with no fresh borrowings involved. Following this creation, Agilemed's encumbered holding increased to 1,34,27,525 shares (11.18% of total share capital), bringing the total encumbered promoter holding across the group to 3,57,77,925 shares, representing 74.10% of total promoter shareholding.
Credit Rating-Reaffirmed for Optival Health Solutions Private Limited, a Material Subsidiary of the Company.
Others (Uncategorized) · 03 Oct 2026, 6:03 pm
CareEdge Reaffirms Credit Ratings for MedPlus Health Subsidiary Optival Health CareEdge Ratings has reaffirmed the credit ratings for Optival Health Solutions Private Limited, a material subsidiary of MedPlus Health Services Limited, as of 3rd Oct'26. The agency reaffirmed the 'CARE A/Stable' rating on long-term bank facilities totaling ₹236.00 crore and the 'CARE A1' rating on short-term bank facilities of ₹14.00 crore. Total rated bank facilities stand at ₹250.00 crore, reflecting sustained credit stability for the operating entity.
MEDPLUS HEALTH SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 27 Oct 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 27 Oct 2026, 5:30 am
Medplus Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Intimation · 27 Oct 2026, 5:30 am
MedPlus Health Schedules Board Meeting to Approve Q2 and H1 FY27 Financial Results MedPlus Health Services Limited has scheduled its Board of Directors meeting on 27th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for designated persons and their immediate relatives will remain closed from 1st Oct'26 until 48 hours following the declaration of the financial results.